38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aspergillus species cause a wide spectrum of clinical infections. Although Aspergillus fumigatus and Aspergillus flavus remain the most commonly isolated species in aspergillosis, in the last decade, rare and cryptic Aspergillus species have emerged in diverse clinical settings. The present study analyzed the distribution and in vitro antifungal susceptibility profiles of rare Aspergillus species in clinical samples from patients with suspected aspergillosis in 8 medical centers in India. Further, a matrix-assisted laser desorption ionization–time of flight mass spectrometry in-house database was developed to identify these clinically relevant Aspergillus species. β-Tubulin and calmodulin gene sequencing identified 45 rare Aspergillus isolates to the species level, except for a solitary isolate. They included 23 less common Aspergillus species belonging to 12 sections, mainly in Circumdati, Nidulantes, Flavi, Terrei, Versicolores, Aspergillus, and Nigri. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) identified only 8 (38%) of the 23 rare Aspergillus isolates to the species level. Following the creation of an in-house database with the remaining 14 species not available in the Bruker database, the MALDI-TOF MS identification rate increased to 95%. Overall, high MICs of ≥2 μg/ml were noted for amphotericin B in 29% of the rare Aspergillus species, followed by voriconazole in 20% and isavuconazole in 7%, whereas MICs of >0.5 μg/ml for posaconazole were observed in 15% of the isolates. Regarding the clinical diagnoses in 45 patients with positive rare Aspergillus species cultures, 19 (42%) were regarded to represent colonization. In the remaining 26 patients, rare Aspergillus species were the etiologic agent of invasive, chronic, and allergic bronchopulmonary aspergillosis, allergic fungal rhinosinusitis, keratitis, and mycetoma.

          Related collections

          Author and article information

          Contributors
          Role: Editor
          Journal
          J Clin Microbiol
          J. Clin. Microbiol
          jcm
          jcm
          JCM
          Journal of Clinical Microbiology
          American Society for Microbiology (1752 N St., N.W., Washington, DC )
          0095-1137
          1098-660X
          13 July 2016
          24 August 2016
          September 2016
          : 54
          : 9
          : 2354-2364
          Affiliations
          [a ]Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India
          [b ]Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India
          [c ]Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands
          [d ]Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands
          University of Iowa College of Medicine
          Author notes
          Address correspondence to Anuradha Chowdhary, dranuradha@ 123456hotmail.com .

          Citation Masih A, Singh PK, Kathuria S, Agarwal K, Meis JF, Chowdhary A. 2016. Identification by molecular methods and matrix-assisted laser desorption ionization–time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a referral chest hospital in Delhi, India. J Clin Microbiol 54:2354–2364. doi: 10.1128/JCM.00962-16.

          Author information
          http://orcid.org/0000-0003-3253-6080
          http://orcid.org/0000-0002-2028-7462
          Article
          PMC5005474 PMC5005474 5005474 00962-16
          10.1128/JCM.00962-16
          5005474
          27413188
          3deb08a7-69bd-48fe-8a80-ab5b58da7847
          Copyright © 2016, American Society for Microbiology. All Rights Reserved.
          History
          : 2 May 2016
          : 8 June 2016
          : 2 July 2016
          Page count
          Figures: 2, Tables: 2, Equations: 0, References: 33, Pages: 11, Words: 9258
          Funding
          This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
          Categories
          Mycology

          Comments

          Comment on this article